Given the known action of curcumin on some immunoinflammatory pathways, the pivotal role of IL-1β and microglia activation in the pathophysiology of depression, and the relevance of these processes to the therapeutic properties of curcumin, we can highlight a probable role for the inflammasomes. Here, IL1B is linked to depressive symptom measurement.